Published in Proc Natl Acad Sci U S A on November 27, 2001
The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A (2002) 2.72
Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med (2006) 2.11
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
The alternative complement pathway revisited. J Cell Mol Med (2008) 1.62
Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol (2003) 1.49
Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci (2008) 1.47
Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun (2008) 1.42
Small-molecule factor D inhibitors targeting the alternative complement pathway. Nat Chem Biol (2016) 1.41
Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. Blood (2017) 1.39
Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood (2007) 1.39
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. Am J Pathol (2003) 1.39
Complement in ischemia reperfusion injury. Am J Pathol (2003) 1.15
Surviving mousepox infection requires the complement system. PLoS Pathog (2008) 1.07
Efficient osteoclast differentiation requires local complement activation. Blood (2010) 1.02
Adipsin is an adipokine that improves β cell function in diabetes. Cell (2014) 1.01
Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun (2013) 0.98
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia (2013) 0.95
Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice. J Biol Chem (2011) 0.95
Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol (2009) 0.94
Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis. J Immunol (2010) 0.94
Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis. J Immunol (2013) 0.93
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood (2013) 0.92
Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2. Infect Immun (2010) 0.91
Induction of IL-17A Precedes Development of Airway Hyperresponsiveness during Diet-Induced Obesity and Correlates with Complement Factor D. Front Immunol (2014) 0.88
The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host. Virulence (2013) 0.87
The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. PLoS One (2013) 0.86
Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Infect Immun (2014) 0.85
Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice. Infect Immun (2011) 0.85
Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis. J Immunol (2011) 0.84
A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense. Curr Respir Med Rev (2006) 0.83
Effects of Streptococcus pneumoniae strain background on complement resistance. PLoS One (2011) 0.83
C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. Clin Exp Immunol (2014) 0.82
Genome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)). FEBS Lett (2007) 0.82
Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects. Clin Exp Immunol (2004) 0.80
Tissue distribution and functional analysis of Sushi domain-containing protein 4. Am J Pathol (2010) 0.80
Retracted Properdin homeostasis requires turnover of the alternative complement pathway. Proc Natl Acad Sci U S A (2010) 0.78
Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin. J Biol Chem (2013) 0.77
Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines. Cytokine (2016) 0.77
An Evaluation of Blood Compatibility of Silver Nanoparticles. Sci Rep (2016) 0.77
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D. J Am Assoc Lab Anim Sci (2010) 0.76
Evolution of the complement system: from defense of the single cell to guardian of the intravascular space. Immunol Rev (2016) 0.75
Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CCl₄-induced injury. Mol Immunol (2014) 0.75
Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery. J Obes (2016) 0.75
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med (1981) 6.45
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 3.89
Origin of murine B cell lineages. Annu Rev Immunol (1993) 3.82
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure (1995) 3.15
CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today (1989) 2.96
Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 2.63
Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A (1997) 2.44
Severely impaired adipsin expression in genetic and acquired obesity. Science (1987) 2.03
Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem (1992) 1.88
Adipsin and complement factor D activity: an immune-related defect in obesity. Science (1989) 1.87
Targeting of nonexpressed genes in embryonic stem cells via homologous recombination. Science (1989) 1.75
An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci U S A (2001) 1.68
A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc Natl Acad Sci U S A (1985) 1.55
Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods (1983) 1.53
Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF). J Immunol (1976) 1.38
Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor. Nucleic Acids Res (1986) 1.34
B-cell lineages exist in the mouse. Immunol Today (1993) 1.30
Linkages of innate and adaptive immunity. Curr Opin Immunol (1998) 1.27
The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest (1993) 1.25
Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis. J Biol Chem (1995) 1.10
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol (1999) 1.10
Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding. J Immunol (1999) 1.09
Metabolic response of Acylation Stimulating Protein to an oral fat load. J Lipid Res (1989) 1.07
Surface loops adjacent to the cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity. Biochemistry (1997) 1.06
Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba. J Immunol (1987) 1.01
A family with complement factor D deficiency. J Clin Invest (2001) 1.00
New structural motifs on the chymotrypsin fold and their potential roles in complement factor B. EMBO J (2000) 0.99
Structural biology of the alternative pathway convertase. Immunol Rev (2001) 0.97
Complete and partial deficiencies of complement factor D in a Dutch family. J Clin Invest (1989) 0.96
Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement. J Biol Chem (1982) 0.94
Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice. J Biol Chem (1999) 0.93
Isolation of complement protein D from urine of patients with Fanconi's syndrome. Anal Biochem (1987) 0.90
cis and trans elements differ among mouse strains with high and low extrahepatic complement factor B gene expression. J Exp Med (1992) 0.88
The effects of metal ions and temperature on the interaction of cobra venom factor and human complement factor B. J Biol Chem (1986) 0.84
Complement factor D deficiency in an infant first seen with pneumococcal neonatal sepsis. J Allergy Clin Immunol (1998) 0.81
Activation of murine complement by cobra venom factor in the presence of EDTA. J Immunol (1979) 0.79
The structural basis of the multiple forms of human complement component C4. Cell (1984) 6.68
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med (1971) 3.32
A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature (1984) 3.27
Aflatoxins: Environmental Factors Governing Occurrence in Spanish Peanuts. Science (1965) 3.09
Effect of corn steep liquor on mycelial growth and aflatoxin production in Aspergillus parasiticus. Appl Microbiol (1966) 2.89
Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A (1985) 2.76
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
Neuroendoscopic approach to intraventricular lesions. J Neurosurg (1998) 2.67
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29
Rabbit C1q: purification, functional and structural studies. J Immunol Methods (1972) 2.15
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J (1985) 2.09
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J (1987) 2.00
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol (2000) 1.95
Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology (1999) 1.94
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
Three dimensional structure of human C-reactive protein. Nat Struct Biol (1996) 1.87
Adipsin and complement factor D activity: an immune-related defect in obesity. Science (1989) 1.87
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect Immun (1989) 1.86
Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med (1996) 1.83
Aflatoxins: production of the toxins in vitro in relation to temperature. Appl Microbiol (1967) 1.81
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
Structure and organization of the C4 genes. Philos Trans R Soc Lond B Biol Sci (1984) 1.78
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J Immunol (1982) 1.77
Karyotypic Variation within Clonal Lineages of the Rice Blast Fungus, Magnaporthe grisea. Appl Environ Microbiol (1993) 1.75
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature (1979) 1.75
Complement activation by C-reactive protein complexes. Ann N Y Acad Sci (1982) 1.75
Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73
Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol (1974) 1.68
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Inhibition of aflatoxin production and tentative identification of an aflatoxin intermediate "versiconal acetate" from treatment with dichlorvos. Appl Microbiol (1974) 1.61
The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med (1996) 1.61
IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth. J Immunol (1999) 1.61
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol (1995) 1.61
Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect Immun (1996) 1.60
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Cloning of a human complement component C4 gene. Proc Natl Acad Sci U S A (1983) 1.56
A macrophage invasion mechanism of pathogenic mycobacteria. Science (1997) 1.55
Neutral endopeptidase modulation of septic shock. J Exp Med (1995) 1.53
Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol (1997) 1.52
The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics (1994) 1.52
Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med (1996) 1.52
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol (2001) 1.48
Aflatoxin-producing potential of isolates of the Aspergillus flavus-oryzae group from peanuts (Arachis hypogaea). Appl Microbiol (1967) 1.47
Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Clin Cancer Res (1999) 1.47
Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol (2000) 1.45
Production of sterigmatocystin by some species of the genus Aspergillus and its toxicity to chicken embryos. Appl Microbiol (1975) 1.45
The role of complement in inflammation and adaptive immunity. Immunol Rev (2001) 1.45
Composition of the immunoglobulin classic antigen-binding site regulates allergic airway inflammation in a murine model of experimental asthma. Clin Exp Allergy (2009) 1.43
Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest (1977) 1.42
Blood clearance of Streptococcus pneumoniae by C-reactive protein. J Immunol (1987) 1.42
Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J (1992) 1.42
Heterogeneity in the human Ig VH locus. J Immunol (1989) 1.41
Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior. J Neurosci Res (2006) 1.39
Isolation and mapping of a polymorphic DNA sequence pH30 on chromosome 4[HGM provisional no. D4S139]. Nucleic Acids Res (1989) 1.37
Humoral response to herpes simplex virus is complement-dependent. Proc Natl Acad Sci U S A (1999) 1.35
Human factor D of the alternative complement pathway: purification and characterization. J Immunol (1977) 1.33
A previously undetected MHC gene with an unusual periodic structure. Science (1988) 1.30
Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A (1989) 1.29
Polymorphism of human complement component C4. Immunogenetics (1985) 1.28
Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol (1996) 1.27
Molecular genetics of the fourth component of human complement and steroid 21-hydroxylase. Immunol Rev (1985) 1.27
Neuroendoscopic approach to intraventricular lesions. Neurosurg Focus (1999) 1.26
Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal Chem (1998) 1.24
Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J Immunol (2001) 1.24
Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience (1998) 1.24
Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol (1994) 1.23
Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med (1998) 1.22
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol (1981) 1.22
Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest (1992) 1.22
Impaired odor adaptation in olfactory receptor neurons after inhibition of Ca2+/calmodulin kinase II. J Neurosci (1999) 1.22
The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation (2001) 1.20
Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. Immunochemistry (1976) 1.20
Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med (1980) 1.19
Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system. Biochem J (1993) 1.19
An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family. Am J Hum Genet (2001) 1.18
Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J Exp Med (1998) 1.18
C-reactive protein: structural biology, gene expression, and host defense function. Immunol Res (1997) 1.18
Zearalenol and 8'-hydroxyzearalenone from Fusarium roseum. Mycopathologia (1975) 1.18
Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol (1994) 1.17